Literature DB >> 30388038

Characterization of MDPL Fibroblasts Carrying the Recurrent p.Ser605del Mutation in POLD1 Gene.

Chiara Fiorillo1, Maria Rosaria D'Apice2, Federica Trucco1, Michela Murdocca3, Paola Spitalieri3, Stefania Assereto1, Serena Baratto1, Guido Morcaldi1, Carlo Minetti1, Federica Sangiuolo2,3, Giuseppe Novelli2,3.   

Abstract

Mandibular hypoplasia, deafness, and progeroid features, with concomitant lipodystrophy, define a multisystem disorder named MDPL syndrome. MDPL has been associated with heterozygous mutations in POLD1 gene resulting in loss of DNA polymerase δ activity. In this study, we report clinical, genetic, and cellular studies of a 13-year-old Pakistani girl, presenting growth retardation, sensorineural deafness, altered distribution of subcutaneous adipose tissue, and insulin resistance. We performed Sanger sequencing of POLD1 gene in the proband and the healthy parents. Fibroblasts obtained from dermal biopsy were evaluated for the specific hallmarks of cellular senescence and for their response to the DNA-induced damage. Patient carried the recurrent heterozygous de novo in frame deletion (c.1812_1814delCTC, p.Ser605del ) within POLD1 gene, previously detected in 16 MDPL patients. In patient's fibroblasts we observed severe nuclear envelope anomalies, presence of micronuclei, accumulation of prelamin A, altered cell growth, and cellular senescence. In addition, we observed a persistence of DNA damage after cisplatin exposure, compared to control cells. In conclusion, the MDPL nuclear and cellular findings resemble features observed in other progeroid syndromes and familial lipodystrophies. Although further investigations will be necessary, these information could be used to establish targeted therapeutic approaches.

Entities:  

Keywords:  DNA repair; MDPL syndrome; POLD1; lipodystrophy; nuclear envelope

Year:  2018        PMID: 30388038     DOI: 10.1089/dna.2018.4335

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  10 in total

1.  SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome.

Authors:  Renuka Kandhaya-Pillai; Deyin Hou; Jiaming Zhang; Xiaomeng Yang; Goli Compoginis; Takayasu Mori; Tamara Tchkonia; George M Martin; Fuki M Hisama; James L Kirkland; Junko Oshima
Journal:  Geroscience       Date:  2021-01-05       Impact factor: 7.713

2.  Mild MDPL in a patient with a novel de novo missense variant in the Cys-B region of POLD1.

Authors:  Maya Chopra; Richard Caswell; Giulia Barcia; Sophie Rondeau; Laurence Jonard; Patrick Nitchké; Daniel Amram; Marc-Lionel Bellaiche; Veronique Abadie; Marine Parodi; Francoise Denoyelle; Andrew Hattersley; Christine Bole; Stanislas Lyonnet; Sandrine Marlin
Journal:  Eur J Hum Genet       Date:  2022-05-20       Impact factor: 5.351

3.  Inactivating Mutations in Exonuclease and Polymerase Domains in DNA Polymerase Delta Alter Sensitivities to Inhibitors of dNTP Synthesis.

Authors:  Jiaming Zhang; Deyin Hou; James Annis; Forough Sargolzaeiaval; Julia Appelbaum; Eishi Takahashi; George M Martin; Alan Herr; Junko Oshima
Journal:  DNA Cell Biol       Date:  2019-11-21       Impact factor: 3.311

4.  Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1.

Authors:  Ye Cui; Sevgi Keles; Louis-Marie Charbonnier; Amélie M Julé; Lauren Henderson; Seyma Celikbilek Celik; Ismail Reisli; Chen Shen; Wen Jun Xie; Klaus Schmitz-Abe; Hao Wu; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2019-10-16       Impact factor: 10.793

5.  Epigenetic signatures of Werner syndrome occur early in life and are distinct from normal epigenetic aging processes.

Authors:  Anna Maierhofer; Julia Flunkert; Junko Oshima; George M Martin; Martin Poot; Indrajit Nanda; Marcus Dittrich; Tobias Müller; Thomas Haaf
Journal:  Aging Cell       Date:  2019-07-01       Impact factor: 9.304

6.  Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.

Authors:  Jérémie Gautheron; Lara Lima; Baris Akinci; Jamila Zammouri; Martine Auclair; Sema Kalkan Ucar; Samim Ozen; Canan Altay; Bridget E Bax; Ivan Nemazanyy; Véronique Lenoir; Carina Prip-Buus; Cécile Acquaviva-Bourdain; Olivier Lascols; Bruno Fève; Corinne Vigouroux; Esther Noel; Isabelle Jéru
Journal:  BMC Med       Date:  2022-03-28       Impact factor: 8.775

7.  Mitochondrial dysfunction in mandibular hypoplasia, deafness and progeroid features with concomitant lipodystrophy (MDPL) patients.

Authors:  Michela Murdocca; Paola Spitalieri; Angela Cappello; Fiorella Colasuonno; Sandra Moreno; Eleonora Candi; Maria Rosaria D'Apice; Giuseppe Novelli; Federica Sangiuolo
Journal:  Aging (Albany NY)       Date:  2022-02-23       Impact factor: 5.682

8.  A hypomorphic mutation in Pold1 disrupts the coordination of embryo size expansion and morphogenesis during gastrulation.

Authors:  Tingxu Chen; Heather Alcorn; Sujan Devbhandari; Dirk Remus; Elizabeth Lacy; Danwei Huangfu; Kathryn V Anderson
Journal:  Biol Open       Date:  2022-08-08       Impact factor: 2.643

9.  EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence.

Authors:  Jeremie Gautheron; Christophe Morisseau; Wendy K Chung; Jamila Zammouri; Martine Auclair; Genevieve Baujat; Emilie Capel; Celia Moulin; Yuxin Wang; Jun Yang; Bruce D Hammock; Barbara Cerame; Franck Phan; Bruno Fève; Corinne Vigouroux; Fabrizio Andreelli; Isabelle Jeru
Journal:  Elife       Date:  2021-08-03       Impact factor: 8.140

10.  Functional analysis of POLD1 p.ser605del variant: the aging phenotype of MDPL syndrome is associated with an impaired DNA repair capacity.

Authors:  Michela Murdocca; Paola Spitalieri; Claudia De Masi; Ion Udroiu; Jessica Marinaccio; Massimo Sanchez; Rosa Valentina Talarico; Chiara Fiorillo; Monica D'Adamo; Paolo Sbraccia; Maria Rosaria D'Apice; Giuseppe Novelli; Antonella Sgura; Federica Sangiuolo
Journal:  Aging (Albany NY)       Date:  2021-02-22       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.